Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Aplaviroc (INN, codenamed AK602 and GSK-873140) is a CCR5 entry inhibitor that belongs to a class of 2,5-diketopiperazines developed for the treatment of HIV infection. It was developed by GlaxoSmithKline.
Overview, Related Topics & Entities
Explore the main themes, entities and connections around Aplaviroc. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
developed discontinued development ccr5 inn hiv glaxosmithkline codenamed ak602 gsk-873140 entry inhibitor belongs class 5-diketopiperazines treatment infection october 2005 studies
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Aplaviroc | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Aplaviroc | ATC code | none | 1.00 | infobox |
| Aplaviroc | CAS Number | 461443-59-4 Y | 1.00 | infobox |
| Aplaviroc | CAS Number | HCl: 461023-63-2 Y | 1.00 | infobox |
| Aplaviroc | ChEMBL | ChEMBL1255794 | 1.00 | infobox |
| Aplaviroc | ChemSpider | 2272720 Y | 1.00 | infobox |
| Aplaviroc | CompTox Dashboard (EPA) | DTXSID6047317 | 1.00 | infobox |
| Aplaviroc | DrugBank | DB06497 Y | 1.00 | infobox |
| Aplaviroc | Formula | C33H43N3O6 | 1.00 | infobox |
| Aplaviroc | IUPHAR/BPS | 805 | 1.00 | infobox |
| Aplaviroc | KEGG | D06557 Y | 1.00 | infobox |
| Aplaviroc | Legal status | Development terminated | 1.00 | infobox |
| Aplaviroc | Molar mass | 577.722 g·mol−1 | 1.00 | infobox |
| Aplaviroc | PubChem CID | 3001322 | 1.00 | infobox |
| Aplaviroc | Routes of administration | Oral | 1.00 | infobox |
| Aplaviroc | UNII | 98B425P30V | 1.00 | infobox |
| Aplaviroc | UNII | HCl: 04D148Z3VR Y | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.